Heron Therapeutics Inc - Company Profile
Powered by
All the data and insights you need on Heron Therapeutics Inc in one report.
- Save hours of research time and resources with
our up-to-date Heron Therapeutics Inc Strategy Report
- Understand Heron Therapeutics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Heron Therapeutics Inc (Heron) uses a proprietary polymer-based drug delivery platform to improve the therapeutic profile of injectable pharmaceuticals. Focused research and development activities, lead product Sustol and proprietary Biochronomer technology are its major strengths, even as declining working capital and a history of operating losses is a cause for concern to the company. Intense Competitive pressure, government regulations and uncertain R&D outcomes could hamper Heron’s business. However, changing demographic trends, increasing healthcare expenditure in the US and regulatory approval could provide growth opportunities to the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer